Bill Gates' chips
Indeed, this is a great joke by Matt Hencock regarding Bill Gates' chips:
"Tell him that considering how many people I’m getting his chips injected into, he owes me one!"
Where are the journalists, where are the law enforcement agencies, where are the people who and whose loved ones have been injured or killed by these technologies?
https://twitter.com/TheWarRoomNZ/status/1632769199843184640
Bill Gates and his PROTEUS BIOMEDICAL:
https://www.ceocfointerviews.com/pdfs/SmartTab20M-CEOCFOMagazine-Preview.pdf
CEOCFO: Mr. Niichel, what is the concept behind SmartTab?
Mr. Niichel: SmartTab is a wireless ingestible capsule that is working on targeted drug delivery for patients.
CEOCFO: How are you able to get what was injectable into a capsule?
Mr. Niichel: It is a proprietary mechanism, so we basically have two methods. You have a capsule that has an injection system, where we can either inject a solid state, which is basically a time released sphere into the side of the stomach or a liquid injection to where there is a poly needle that is injected first and then we follow on with the liquid. Therefore, either we can injection the dry state through the proprietary pharmaceutical grade implant needles or we can do a liquid state.
CEOCFO: Would you explain what wireless means? What is the technology that is allowing this to happen once it is injected?
Mr. Niichel: The wireless business is really neat. Now you can control the way the active ingredients are released in the capsule. You can monitor the location of the capsule. You have a two-way communication with the capsule that will either track where it is, or you can control where it is. The wireless piece also has sensors in it, so there is a temperature sensor, there is a pH sensor. Those are twofold, number one, not only to trigger when the reactive ingredients are triggered to release, per the pH sensor, the temperature sensor, but also to monitor the internal vitals of a person. We can add more sensors as the technology grows, but this idea of having wireless communication with your cell phone and iWatch, or a PC in a clinical setting.
There is a company called Proteus that has made some very good progress for a chip that they embed into a single tablet that tracks when you consume the active ingredient. They do not do a drug delivery, it is just basically a simple tablet, they can add a chip to it. However, they do have it commercialized and their partnership with Otsuka Pharmaceutical Co., Ltd. and they do have FDA approval on the device.
https://web.archive.org/web/20180103192837/https://bloximages.newyork1.vip.townnews.com/dothaneagle.com/content/tncms/assets/v3/eedition/4/9b/49ba9955-36c9-502b-8a03-1b3860d4f3d7/5a224b12a8476.pdf.pdf US regulators approve first digital pill to track patients
These privacy issues are likely to crop up more often as drug-makers and medical device companies combine their products with technologies developed by SiliconValley...
https://web.archive.org/web/20120620163405/http://www.weforum.org/pdf.php?
Privacy remains a thorny issue in digital health, with unresolved questions over who actually owns patient data: Is it the patients themselves? Or perhaps the companies providing digital health solutions? Or healthcare providers? Or governments?
https://web.archive.org/web/20130523013419/http://proteusdigitalhealth.com/company/partners
FDA approves Abilify MyCite from Proteus-Otsuka, first pill with embedded sensor that tracks ingestion via wearable patch, app; diabetes implications? - November 20, 2017 Executive Highlights
It will be rolled out in a limited fashion next year, though pricing hasn't yet been established. Proteus's sensor can be packaged and delivered in three ways, and this is the first approved indication to be directly integrated into the pill (i.e., at the manufacturing level). ▪ We see this as another opportunity to capture non-existent data, learn more about real-world use, and drive smarter reimbursement and outcomes tracking. ▪ This technology is promising, but, carries a few potential barriers to uptake: (i) The ability of the system to improve "compliance" has not yet been established - a study will likely commence after sales begin; (ii) The patch, which looks bulky and caused skin irritation in 12.4% of cases in trials, demands adherence in its own right!; and (iii)
There is concern over privacy, as it has been compared to a "biomedical Big Brother" (see NYT).
▪ We last covered Proteus in depth three years ago, when it raised $52 million in Series G financing. We've seen the company at multiple conferences since, but with no diabetes updates - SXSW 2017 (general comments on fitting products into "life flow"), ACC 2016 (see BP outcomes below), CES 2016 (brief mention of structured glucose testing), ACC 2015 (comments on digital medicine), and SXSW 2015 (comments on making design "invisible"). ▪ Below, we discuss a competitive landscape with at least 12 companies working on improving pill tracking through passive data capture and novel packaging. Just last week, Proteus, Otsuka, and the FDA announced approval of Abilify MyCite, the first pill with an embedded sensor that digitally tracks if patients have taken their medication. Abilify MyCite was resubmitted to FDA in May after a complete response letter was issued in April 2016 - FDA had requested additional information, including further human factors investigations. The system consists of tablets embedded with Ingestible Event Marker (IEM) sensors containing copper, magnesium, and silicon that generate an electric signal in the acidic environment of the stomach (it's the size of a grain of sand).'
http://rimed.org/rimedicaljournal/2020/10/2020-10-23-perspective-hagan.pdf Implied Yet Unproven: The Digital Pill – Present and Future'
👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆👆
That's why they need "Pandemic", because it "empowers" them suddenly to do/implement whatever they want, to introduce any type of dictatorship and inject/instill any “chips”/unproven technologies/devices/experimental "drugs", etc.
It is a population tagging that is harmful and lethal and has nothing to do with health.
It is a crime.
Just have a look at this technology and what it is related to:
Ingestible therapy activator system and method
Claims
What is claimed is:
1. A system for providing instructions to a therapeutic device, the system comprising: an ingestible unit comprising: a housing; and an effector module secured within the housing for providing an effector instruction, wherein the housing dissolves upon contact with the surrounding fluid of a desired target site to release the effector module and the effector module comprises a support structure including two dissimilar materials deposited thereon wherein the dissimilar materials represent a voltage potential difference and provide power for the ingestible unit upon contact with the fluid; a responder module in communication with the therapeutic device for receiving and processing the effector instruction, wherein the effector instruction alters at least an operation of the therapeutic device; and a hermetically sealed conductance control module electrically coupled to each of the dissimilar materials for controlling the conductance between the dissimilar materials to generate a unique current signature that presents the effector instruction, wherein the current signature is produced through controlled ionic emission.
2. The system of claim 1, wherein the ingestible unit further comprises an oral medication.
3. The system of claim 1, wherein the ingestible unit further comprises a second effector module secured within the housing to provide a second effector instruction.
4. The system of claim 1, wherein the effector instruction further comprises data.
5. The system of claim 1, wherein the responder module further comprises a transmitter to transmit at least one of data and signals.
6. The system of claim 1, further comprising the therapeutic device.
7. The system of claim 6, wherein the therapeutic device is a cardiac device.
8. The system of claim 7, wherein the cardiac device is a lead device.
9. The system of claim 6, wherein the therapeutic device is a selected from a group consisting essentially of an electrode device, a migraine device, a urinary device, and a gastrointestinal device.
10. The system of claim 1, wherein the responder module comprises at least one of a hardware component and a software component.
FIELD OF THE INVENTION
The present invention relates generally to medical therapy systems, devices, and methods. More specifically, the invention relates to systems, devices, and methods for activation and/or modulation of various medical therapies using an ingestible electronic device.
SUMMARY
The present disclosure includes a system for providing instructions to a therapeutic device. The therapeutic device can be any type of device, such as a cardiac therapeutic device, a neural stimulation device, an intrathecal drug delivery pump, a gastrointestinal device; and a neural stimulation prosthesis. The system includes an ingestible unit and a responder module. The ingestible unit includes an output or effector module that provides an effector instruction to the responder module. The responder module receives and processes the effector instruction and communicates the effector instruction to the therapeutic device to alter the operation of the therapeutic device.
Other References:
Aydin et al., "Design and implementation considerations for an advanced wireless interface in miniaturized integrated sensor Microsystems" Sch. of Eng. & Electron., Edinburgh Univ., UK; (2003);
Brock, "Smart Medicine: The Application of Auto-ID Technology to Healthcare" Auto-ID Labs (2002) http://www.autoidlabs.org/uploads/media/MIT-AUTOID-WH-010.pdf;
"RFID "pill" monitors marchers" RFID News (2008) http://www.rfidnews.org/2008/07/23/rfid-pill-monitors-marchers/;
"The SmartPill Wireless Motility Capsule" SMARTPILL, The Measure of GI Health; http://www.smartpillcorp.com/index.cfm?pagepath=Products/The.sub.- --SmartPill.sub.--Capsule&id;=17814;
Solanas et al., "RFID Technology for the Health Care Sector" Recent Patents on Electrical Engineering (2008) 1, 22-31;
Swedberg, "University Team Sees Ingestible RFID Tag as a Boon to Clinical Trials" RFID Journal Apr. 27, 2010; http://www.rfidjournal.com/article/view/7560/1;
Carlson et al., "Evaluation of a non-invasive respiratory monitoring system for sleeping subjects" Physiological Measurement (1999) 20(1): 53
Mackay et al., "Radio Telemetering from within the Body" Inside Information is Revealed by Tiny Transmitters that can be Swallowed or Implanted in Man or Animal Science (1991) 1196-1202; 134; American Association for the Advancement of Science, Washington D.C.
Tatbul et al., "Confidence-based data management for personal area sensor networks" ACM International Conference Proceeding Series (2004) 72;
Xiaoming et al., "A telemedicine system for wireless home healthcare based on bluetooth and the internet" Telemedicine Journal and e-health (2004) 10(S2): S110-6;
Yao et al., "Low Power Digital Communication in Implantable Devices Using Volume Conduction of Biological Tissues" Proceedings of the 28th IEEE, EMBS Annual International Conference, Aug. 30-Sep. 3, 2006;
Zimmerman, "Personal Area Networks: Near-field intrabody communication" IBM Systems Journal (1996) 35 (3-4):609-17
"Smartlife awarded patent for knitted transducer" Innovation in Textiles News: http://www.innovationintextiles.com/articles/208.php; 2pp. (2009)
Santini, J.T. et al, "Microchips as controlled drug delivery-devices", Agnew. Chem. Int. Ed. 2000, vol. 39, p. 2396-2407
https://patents.justia.com/inventor/mark-j-zdeblick
http://www.ijarset.com/upload/2018/february/16-IJARSET-khan.pdf Implantable Bio-MEMS for the treatment of Cance
Discharge of the drug solution from this device and the release rates are controlled by an external magnetic field.
The biocompatibility of the implanted BioMEMS devices is an important factor to be considered [30]. Care must be taken since it will be implanted in the body for a long period of time and it will interact with tissues in the body. Following four factors should be considered when designing an implantable BioMEMS device: (i) the impact of the implantable device on the immune response, (ii) minimizing biofouling on the implanted device, (iii) the physical effect of the implant on the surrounding tissues, and (iv) the degree of cell adhesion achieved by the implanted device.
…
TOXICITY? INFORMED CONSENT? TRANSPARENCY REGARDING CONTRACTS, ADVERSE EFFECTS, COMPONENTS USED? SCIENCE? JOURNALISM? LAW?
Leaked WhatsApps showed Damon Poole, the Health Secretary's media adviser asking Mr Hancock whether he had spoken to Tedros Adhanom Ghebreyesus, the director general of the World Health Organisation, about the New Variant Assessment Platform (NVAP) - a service offering other countries UK expertise to detect and assess new variants around the world.
When Mr Hancock confirmed that he had spoken to him, Mr Poole said: "No promises but I’m trying to land a Bill Gates endorsement of the platform".
In response, the Health Secretary WROTE: "Tell him that considering how many people I’m getting his chips injected into, he owes me one!"
Very interesting! Could this be the technology that they will claim “cured” King Charles of his apparent cancer? Sure looks like this was the end goal all along.. implants for digital tracking. Soften up the targets with a faked pandemic,fake vaccine/cancer causing agent and then reveal the miracle of digital health implants to “monitor” the next planned event or cancer treatment. 2024 is going to prove quite the year, the PsyOps will be relentless
Wow, I was searching for literature for my pet hypothesis too. 😊🧐
Cu1+ catalyst these one utilze Ti Si and Ag with Cu1Ti catalyst on TiO2. Biomedical hydrogel.
https://www.sciencedirect.com/science/article/abs/pii/S2211285522009302